Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-9616
Dreiseitel, A; Schreier, P; Oehme, A; Locher, S; Rogler, G; Piberger, H; Hajak, G; Sand, P G (2008). Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochemical and Biophysical Research Communications (BBRC), 372(1):57-61.
|PDF - Registered users only|
Recent reports have demonstrated multiple benefits associated with the consumption of berry fruits, including a decreased vulnerability to oxidative stress, reduced ischemic brain damage, protection of neurons from stroke-induced damage and the reversal of age-related changes in brain and behaviour. Berry fruits contain high amounts of anthocyanins, which play a major role as free radical scavengers. The present study addresses proteasome inhibition as a further mechanism by which anthocyanins and their aglycons, the anthocyanidins, may exert health-promoting effects. HL-60 cells were incubated with 19 test substances and inhibition of the chymotrypsin-like enzyme activity was determined in a chemiluminescent assay. Anthocyanins and their aglycons achieved IC(50) values ranging from 7.8 microM for kaempferidinidin and pelargonidin, to 32.4 microM for delphinidin. Thus proteasome inhibitory properties of anthocyanins may contribute to their known anticarcinogenic, antioxidative, anti-inflammatory and neuroprotective activities, rationalizing dietary supplementations with anthocyanins in the prevention and treatment of chronic diseases, including neurodegenerative disorders.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Gastroenterology and Hepatology|
|DDC:||610 Medicine & health|
|Date:||18 July 2008|
|Deposited On:||12 Jan 2009 13:42|
|Last Modified:||23 Nov 2012 16:08|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page